
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
The Royal Wolverhampton NHS Trust is one of the largest NHS trusts in the West Midlands providing primary, acute and community services and we are incredibly proud of the diversity of both our staff and the communities we serve. We are building a workforce that can help us to fulfil our values, improve quality of care for patients, and solve the health care problems of tomorrow. We're passionate about the value that diversity of thinking and lived experience brings in enabling us to become a learning organisation and leader in delivering compassionate care for our patients.
We are delighted that we have been rated asGoodby CQC. We have achieved numerous awards: The Nursing Times Best Diversity and Inclusion Practice and Best UK Employer of the Year for Nursing Staff in 2020.
The Department has an active interest in clinical research and we currently have commercial and academic trials in the fields of Lymphoma, Myeloma and Acute Myeloid Leukemia.
Professor Basu leads the West Midlands Research Consortium (WMRC).
We have a 22 bedded inpatient facility providing care for patients undergoing induction treatment for Acute Leukemia and salvage treatment for Lymphoma.
You will manage both inpatients and outpatients and carry out diagnostic haematology (blood film and bone marrow reporting). You are expected to participate in a 1:8 on call rota covering weekdays and weekends, provide consultative haematology advice to different healthcare professionals and work across three sites: New Cross Hospital, Cannock Chase Hospital and Walsall. The Trust actively welcomes applicants with an interest in malignant, thrombosis and haemostasis and haemoglobinopathies.